ASX - By Stock
|
IMM |
Re:
Ann: Cleansing Notice
|
|
Bylosellhi
|
4 |
1.9K |
6 |
12/06/24 |
12/06/24 |
ASX - By Stock
|
4
|
1.9K
|
6
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Cleansing Notice
|
|
Bylosellhi
|
4 |
1.9K |
2 |
12/06/24 |
12/06/24 |
ASX - By Stock
|
4
|
1.9K
|
2
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
Bylosellhi
|
2.7K |
1.1M |
3 |
11/06/24 |
11/06/24 |
ASX - By Stock
|
2.7K
|
1.1M
|
3
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep letter to ineligible shareholders
|
|
Bylosellhi
|
4 |
2.6K |
0 |
07/06/24 |
07/06/24 |
ASX - By Stock
|
4
|
2.6K
|
0
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
Bylosellhi
|
2.7K |
1.1M |
0 |
07/06/24 |
07/06/24 |
ASX - By Stock
|
2.7K
|
1.1M
|
0
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep completes institutional pro-rata offer & placement
|
|
Bylosellhi
|
44 |
16K |
14 |
06/06/24 |
06/06/24 |
ASX - By Stock
|
44
|
16K
|
14
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep completes institutional pro-rata offer & placement
|
|
Bylosellhi
|
44 |
16K |
14 |
06/06/24 |
06/06/24 |
ASX - By Stock
|
44
|
16K
|
14
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep Capital Raising Presentation
|
|
Bylosellhi
|
8 |
3.8K |
11 |
05/06/24 |
05/06/24 |
ASX - By Stock
|
8
|
3.8K
|
11
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep Capital Raising Presentation
|
|
Bylosellhi
|
8 |
3.8K |
6 |
05/06/24 |
05/06/24 |
ASX - By Stock
|
8
|
3.8K
|
6
|
|
ASX - By Stock
|
IMM |
Re:
What have we got?
|
|
Bylosellhi
|
42 |
27K |
16 |
29/05/24 |
29/05/24 |
ASX - By Stock
|
42
|
27K
|
16
|
|
ASX - By Stock
|
IMM |
Re:
What have we got?
|
|
Bylosellhi
|
42 |
27K |
18 |
28/05/24 |
28/05/24 |
ASX - By Stock
|
42
|
27K
|
18
|
|
ASX - By Stock
|
IMM |
Re:
What have we got?
|
|
Bylosellhi
|
42 |
27K |
1 |
23/05/24 |
23/05/24 |
ASX - By Stock
|
42
|
27K
|
1
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
Bylosellhi
|
2.7K |
1.1M |
6 |
13/05/24 |
13/05/24 |
ASX - By Stock
|
2.7K
|
1.1M
|
6
|
|
ASX - By Stock
|
IMM |
Re:
EFTI at 90
|
|
Bylosellhi
|
42 |
17K |
1 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
42
|
17K
|
1
|
|
ASX - By Stock
|
IMM |
Re:
EFTI at 90
|
|
Bylosellhi
|
42 |
17K |
6 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
42
|
17K
|
6
|
|
ASX - By Stock
|
IMM |
Re:
TACTI-003 likelihood of success based on data comparison
|
|
Bylosellhi
|
2 |
1.4K |
4 |
25/04/24 |
25/04/24 |
ASX - By Stock
|
2
|
1.4K
|
4
|
|
ASX - By Stock
|
IMM |
Re:
Ann: CHDR to conduct first-in-human phase 1 trial of IMP761
|
|
Bylosellhi
|
10 |
4.4K |
10 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
10
|
4.4K
|
10
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Ceasing to be a substantial holder
|
|
Bylosellhi
|
11 |
5.2K |
2 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
11
|
5.2K
|
2
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
Bylosellhi
|
743 |
338K |
4 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
743
|
338K
|
4
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
Bylosellhi
|
743 |
338K |
0 |
05/04/24 |
05/04/24 |
ASX - By Stock
|
743
|
338K
|
0
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
Bylosellhi
|
743 |
338K |
4 |
25/03/24 |
25/03/24 |
ASX - By Stock
|
743
|
338K
|
4
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
Bylosellhi
|
743 |
338K |
21 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
743
|
338K
|
21
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
Bylosellhi
|
743 |
338K |
10 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
743
|
338K
|
10
|
|
ASX - By Stock
|
IMM |
Re:
Ann: First Clinical Data announced from 90mg Dosing of Efti
|
|
Bylosellhi
|
56 |
30K |
1 |
15/03/24 |
15/03/24 |
ASX - By Stock
|
56
|
30K
|
1
|
|
ASX - By Stock
|
IMM |
Re:
Ann: First Clinical Data announced from 90mg Dosing of Efti
|
|
Bylosellhi
|
56 |
30K |
4 |
13/03/24 |
13/03/24 |
ASX - By Stock
|
56
|
30K
|
4
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
Bylosellhi
|
2.7K |
1.1M |
13 |
08/03/24 |
08/03/24 |
ASX - By Stock
|
2.7K
|
1.1M
|
13
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
Bylosellhi
|
2.7K |
1.1M |
1 |
06/03/24 |
06/03/24 |
ASX - By Stock
|
2.7K
|
1.1M
|
1
|
|
ASX - By Stock
|
IMM |
Re:
Ann: First Clinical Data announced from 90mg Dosing of Efti
|
|
Bylosellhi
|
56 |
30K |
22 |
05/03/24 |
05/03/24 |
ASX - By Stock
|
56
|
30K
|
22
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
Bylosellhi
|
2.7K |
1.1M |
11 |
29/02/24 |
29/02/24 |
ASX - By Stock
|
2.7K
|
1.1M
|
11
|
|
ASX - By Stock
|
IMM |
Re:
An obsevation re Eftiligomab alfa
|
|
Bylosellhi
|
24 |
8.7K |
4 |
19/02/24 |
19/02/24 |
ASX - By Stock
|
24
|
8.7K
|
4
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
Bylosellhi
|
743 |
338K |
1 |
05/02/24 |
05/02/24 |
ASX - By Stock
|
743
|
338K
|
1
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
Bylosellhi
|
743 |
338K |
4 |
10/01/24 |
10/01/24 |
ASX - By Stock
|
743
|
338K
|
4
|
|
ASX - By Stock
|
IMM |
Re:
Is 2024 Efti's year?....
|
|
Bylosellhi
|
13 |
7.5K |
9 |
01/01/24 |
01/01/24 |
ASX - By Stock
|
13
|
7.5K
|
9
|
|
ASX - By Stock
|
IMM |
Re:
The reason for the price increase ???
|
|
Bylosellhi
|
19 |
11K |
2 |
18/12/23 |
18/12/23 |
ASX - By Stock
|
19
|
11K
|
2
|
|
ASX - By Stock
|
IMM |
Re:
Only a matter of time
|
|
Bylosellhi
|
19 |
11K |
1 |
27/11/23 |
27/11/23 |
ASX - By Stock
|
19
|
11K
|
1
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep Completes Enrolment for TACTI-003 Phase IIb Trial
|
|
Bylosellhi
|
17 |
9.6K |
7 |
10/11/23 |
10/11/23 |
ASX - By Stock
|
17
|
9.6K
|
7
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep Completes Enrolment for TACTI-003 Phase IIb Trial
|
|
Bylosellhi
|
17 |
9.6K |
19 |
09/11/23 |
09/11/23 |
ASX - By Stock
|
17
|
9.6K
|
19
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
Bylosellhi
|
2.7K |
1.1M |
3 |
08/11/23 |
08/11/23 |
ASX - By Stock
|
2.7K
|
1.1M
|
3
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep to Participate in November Investor Events
|
|
Bylosellhi
|
2 |
1.4K |
17 |
02/11/23 |
02/11/23 |
ASX - By Stock
|
2
|
1.4K
|
17
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep reports promising data from INSIGHT-003 trial
|
|
Bylosellhi
|
10 |
5.4K |
13 |
26/10/23 |
26/10/23 |
ASX - By Stock
|
10
|
5.4K
|
13
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep receives Australian R&D Tax Incentive
|
|
Bylosellhi
|
2 |
1.0K |
0 |
25/10/23 |
25/10/23 |
ASX - By Stock
|
2
|
1.0K
|
0
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
Bylosellhi
|
2.7K |
1.1M |
19 |
21/10/23 |
21/10/23 |
ASX - By Stock
|
2.7K
|
1.1M
|
19
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
Bylosellhi
|
2.7K |
1.1M |
5 |
11/10/23 |
11/10/23 |
ASX - By Stock
|
2.7K
|
1.1M
|
5
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
Bylosellhi
|
2.7K |
1.1M |
9 |
28/09/23 |
28/09/23 |
ASX - By Stock
|
2.7K
|
1.1M
|
9
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
Bylosellhi
|
2.7K |
1.1M |
0 |
27/09/23 |
27/09/23 |
ASX - By Stock
|
2.7K
|
1.1M
|
0
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Commercial Scale Manufacturing of Efti for Clinical Trials
|
|
Bylosellhi
|
29 |
13K |
1 |
22/09/23 |
22/09/23 |
ASX - By Stock
|
29
|
13K
|
1
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
Bylosellhi
|
743 |
338K |
2 |
06/09/23 |
06/09/23 |
ASX - By Stock
|
743
|
338K
|
2
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep Investor Update
|
|
Bylosellhi
|
7 |
4.0K |
1 |
18/08/23 |
18/08/23 |
ASX - By Stock
|
7
|
4.0K
|
1
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
Bylosellhi
|
2.7K |
1.1M |
2 |
03/08/23 |
03/08/23 |
ASX - By Stock
|
2.7K
|
1.1M
|
2
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
Bylosellhi
|
743 |
338K |
0 |
24/07/23 |
24/07/23 |
ASX - By Stock
|
743
|
338K
|
0
|
|